Clinical Trial Update: BGS649 Monotherapy in Moderate to Severe Endometriosis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BGS649 monotherapy in moderate to severe endometriosis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• BGS649

Snippet

Sponsor: Mereo BioPharma | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2017-12-14